{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T05:03:50Z","timestamp":1784610230791,"version":"3.55.0"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Pediatric tumor-induced osteomalacia (TIO), also called Tumor-induced rickets (TIR), is characterized by renal phosphate wasting, resulting in hypophosphatemia and rickets. This study aimed to evaluate the clinical characteristics of pediatric TIO patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A systematic search was performed on December 26, 2025, in PubMed, Elsevier, SpringerLink, the China National Knowledge Infrastructure, and Wanfang\u00a0Data using the terms: \u201ctumor-induced rickets,\u201d \u201ctumor-induced hypophosphatemic rickets,\u201d \u201concogenic osteomalacia,\u201d \u201chypophosphatemia,\u201d \u201ctumor-induced osteomalacia,\u201d \u201cchildren,\u201d \u201cchild,\u201d and \u201cpediatrics\u201d. Studies published in English and Chinese were included. This review was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses criteria.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 62 pediatric TIO cases were included. Pediatric TIO was more frequent in males, who exhibited a higher proportion of weakness and deformities compared with females. 16.1% of patients were misdiagnosed with another condition. Somatostatin receptor-based imaging modalities demonstrated a high proportion for identifying these tumors. Pediatric TIO-causing neoplasms were predominantly located in the lower extremities and primarily originated from the bone tissue. Benign tumors were more common than malignant ones. The latter were associated with lower serum calcium levels. Surgery is the preferred definitive treatment for pediatric TIO, with an 84.2% resolution proportion.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Pediatric TIO affects males more frequently than females, with male patients exhibiting a higher proportion of weakness and deformities, and is prone to misdiagnosis. Neoplasms are mostly located in the lower extremities and are predominantly benign. Surgery is the preferred treatment for pediatric TIO. For hypophosphatemic pediatric patients, TIO should be considered to preventing adverse outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1871968","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T04:19:38Z","timestamp":1784607578000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical characteristics of pediatric tumor-induced osteomalacia: a systematic review and individual patient data analysis"],"prefix":"10.3389","volume":"17","author":[{"given":"Rong","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Osteoporosis, Beijing Jishuitan Hospital, Capital Medical University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhangxin","family":"Wen","sequence":"additional","affiliation":[{"name":"Department of Metabolic Endocrinology, Zhuzhou Hospital Affiliated to Xiangya School of Medicine, Central South University","place":["Zhuzhou, Hunan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Osteoporosis, Beijing Jishuitan Hospital, Capital Medical University","place":["Beijing, China"]},{"name":"Laboratory for Clinical Medicine, Capital Medical University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinping","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Osteoporosis, Beijing Jishuitan Hospital, Capital Medical University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyi","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Osteoporosis, Beijing Jishuitan Hospital, Capital Medical University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Metabolic Endocrinology, Zhuzhou Hospital Affiliated to Xiangya School of Medicine, Central South University","place":["Zhuzhou, Hunan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailing","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Osteoporosis, Beijing Jishuitan Hospital, Capital Medical University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"R57","DOI":"10.1530\/jme-20-0089","article-title":"FGF23-related hypophosphatemic rickets\/osteomalacia: diagnosis and new treatment","volume":"66","author":"Fukumoto","year":"2021","journal-title":"J Mol Endocrinol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2021.116064","article-title":"Challenges in the management of tumor-induced osteomalacia (TIO)","volume":"152","author":"Brandi","year":"2021","journal-title":"Bone"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-014-2979-0","article-title":"Tumor-associated FGF-23-induced hypophosphatemic rickets in children: a case report and review of the literature","volume":"30","author":"Burckhardt","year":"2015","journal-title":"Pediatr Nephrol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/bf02029356","article-title":"Tumour-induced rickets: a case report and review of the literature","volume":"154","author":"Eyskens","year":"1995","journal-title":"Eur J Pediatr"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.3903","article-title":"Nonremission and recurrent tumor-induced osteomalacia: a retrospective study","volume":"35","author":"Li","year":"2020","journal-title":"J Bone Miner Res"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1111\/joim.13593","article-title":"Global guidance for the recognition, diagnosis, and management of tumor-induced osteomalacia","volume":"293","author":"Jan de Beur","year":"2023","journal-title":"J Intern Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-022-06432-9","article-title":"A literature review to understand the burden of disease in people living with tumour-induced osteomalacia","volume":"33","author":"Minisola","year":"2022","journal-title":"Osteoporos Int"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgae431","article-title":"Healthcare resource use associated with tumor-induced osteomalacia: a literature review","volume":"110","author":"Jan de Beur","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies","volume":"155","author":"Whiting","year":"2011","journal-title":"Ann Intern Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-022-03039-2","article-title":"Persistence and recurrence in tumor-induced osteomalacia: a systematic review of the literature and results from a national survey\/case series","volume":"76","author":"Cianferotti","year":"2022","journal-title":"Endocrine"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.radcr.2025.11.017","article-title":"Tumor-induced osteomalacia mimicking metastases on Ga-68 DOTATATE scan: a rare pericytic variant of phosphaturic mesenchymal tumor","volume":"21","author":"Abandeh","year":"2026","journal-title":"Radiol Case Rep"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1186\/s13256-021-03220-7","article-title":"Tumor-induced osteomalacia: a case report","volume":"16","author":"Aligail","year":"2022","journal-title":"J Med Case Rep"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2003.12.025","article-title":"Resolution of severe, adolescent-onset hypophosphatemic rickets following resection of an FGF-23-producing tumour of the distal ulna","volume":"34","author":"Ward","year":"2004","journal-title":"Bone"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.bonr.2024.101772","article-title":"Tumor-induced osteomalacia: a systematic literature review","volume":"21","author":"\u00c1lvarez-Rivas","year":"2024","journal-title":"Bone Rep"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.EJ16-0587","article-title":"The diagnostic dilemma of tumor induced osteomalacia: a retrospective analysis of 144 cases","volume":"64","author":"Feng","year":"2017","journal-title":"Endocr J"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1210\/endrev\/bnac026","article-title":"Tumor-induced osteomalacia: a comprehensive review","volume":"44","author":"Minisola","year":"2023","journal-title":"Endocr Rev"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.4331","article-title":"Early discrimination between tumor-induced rickets\/osteomalacia and X-linked hypophosphatemia in Chinese children and adolescents: a retrospective case-control study","volume":"36","author":"Jiajue","year":"2021","journal-title":"J Bone Miner Res"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2016-2052","article-title":"(68)Ga-DOTATATE for tumor localization in tumor-induced osteomalacia","volume":"101","author":"El-Maouche","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2014.04.016","article-title":"68Ga DOTA-TATE PET\/CT allows tumor localization in patients with tumor-induced osteomalacia but negative 111In-octreotide SPECT\/CT","volume":"64","author":"Breer","year":"2014","journal-title":"Bone"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbo.2024.100600","article-title":"Preoperative evaluation and orthopedic surgical strategies for tumor-induced osteomalacia","volume":"45","author":"Liu","year":"2024","journal-title":"J Bone Oncol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvac181","article-title":"Utility of multimodality approach including systemic FGF23 venous sampling in localizing phosphaturic mesenchymal tumors","volume":"7","author":"Kato","year":"2022","journal-title":"J Endocr Soc"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.116.182899","article-title":"Operational and dosimetric aspects of pediatric PET\/CT","volume":"58","author":"Fahey","year":"2017","journal-title":"J Nucl Med"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.4314\/ejhs.v30i5.16","article-title":"Justification and optimization principles of ALARA in pediatric CT at a teaching hospital in Ethiopia","volume":"30","author":"Solomon","year":"2020","journal-title":"Ethiop J Health Sci"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgac253","article-title":"Tumor-induced osteomalacia: a systematic review and individual patient's data analysis","volume":"107","author":"Rendina","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-022-01005-8","article-title":"Tumor-induced osteomalacia: a systematic clinical review of 895 cases","volume":"111","author":"Bosman","year":"2022","journal-title":"Calcif Tissue Int"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.1642","article-title":"Tumor-induced osteomalacia: an important cause of adult-onset hypophosphatemic osteomalacia in China: report of 39 cases and review of the literature","volume":"27","author":"Jiang","year":"2012","journal-title":"J Bone Miner Res"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinimag.2019.04.007","article-title":"Tumor-induced osteomalacia - current imaging modalities and a systematic approach for tumor localization","volume":"56","author":"Rayamajhi","year":"2019","journal-title":"Clin Imaging"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgad690","article-title":"Clinical characteristics of Malignant phosphaturic mesenchymal tumor causing tumor-induced osteomalacia","volume":"109","author":"Abate","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgae183","article-title":"A retrospective cohort of tumor-induced osteomalacia and case series of Malignant disease","volume":"110","author":"Hoong","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.6065\/apem.2019.24.4.213","article-title":"Skeletal mineralization: mechanisms and diseases","volume":"24","author":"Michigami","year":"2019","journal-title":"Ann Pediatr Endocrinol Metab"},{"key":"B31","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.pcl.2018.09.004","article-title":"Hypophosphatemic rickets","volume":"66","author":"Bitzan","year":"2019","journal-title":"Pediatr Clin North Am"},{"key":"B32","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12943-016-0545-z","article-title":"Long non-coding RNAs: potential new biomarkers for predicting tumor invasion and metastasis","volume":"15","author":"Jiang","year":"2016","journal-title":"Mol Cancer"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1093\/jbmr\/zjaf148","article-title":"Skeletal involvement in tumor-induced osteomalacia","volume":"41","author":"Minisola","year":"2025","journal-title":"J Bone Miner Res"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1097\/cm9.0000000000001448","article-title":"Consensus on clinical management of tumor-induced osteomalacia","volume":"134","author":"Jiang","year":"2021","journal-title":"Chin Med J (Engl)"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.4233","article-title":"Burosumab for the treatment of tumor-induced osteomalacia","volume":"36","author":"Jan de Beur","year":"2021","journal-title":"J Bone Miner Res"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-022-06516-6","article-title":"Long-term use of burosumab for the treatment of tumor-induced osteomalacia","volume":"34","author":"Crotti","year":"2023","journal-title":"Osteoporos Int"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.3468","article-title":"Model-informed approach to recommend burosumab dosing regimens for pediatric and adult patients with the ultrarare disease tumor-induced osteomalacia","volume":"116","author":"Hruska","year":"2024","journal-title":"Clin Pharmacol Ther"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1093\/jbmr\/zjaf047","article-title":"Tumor-induced rickets\/osteomalacia (TIO): diagnostic pitfalls and therapeutic options","volume":"40","author":"Ito","year":"2025","journal-title":"J Bone Miner Res"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-025-07469-2","article-title":"Oncogenic rickets diagnosed at age 8 and the risk of persistent rickets: a rare case of pediatric-onset tumor-induced osteomalacia","volume":"36","author":"Lasnier-Siron","year":"2025","journal-title":"Osteoporos Int"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.4620","article-title":"Clinical challenges in diagnosis, tumor localization and treatment of tumor-induced osteomalacia: outcome of a retrospective surveillance","volume":"37","author":"Hidaka","year":"2022","journal-title":"J Bone Miner Res"},{"key":"B41","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s11914-012-0098-z","article-title":"Vitamin D and bone","volume":"10","author":"Bikle","year":"2012","journal-title":"Curr Osteoporos Rep"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1871968\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T04:19:39Z","timestamp":1784607579000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1871968\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,21]]},"references-count":41,"alternative-id":["10.3389\/fendo.2026.1871968"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1871968","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,21]]},"article-number":"1871968"}}